Literature DB >> 24954081

Paraneoplastic neuromyelitis optica spectrum disorder associated with stomach carcinoid tumor.

Talal Al-Harbi1, Adnan Al-Sarawi2, Mohamed Binfalah3, Said Dermime4.   

Abstract

Neuromyelitis optica (NMO), or Devic's syndrome, is an autoimmune central nervous system demyelinating disorder primarily affecting the spinal cord and the optic nerves. It is characterized by the presence of NMO antibodies, alongside clinical and radiological findings. NMO and NMO-spectrum disorders (NMO-SD) have been reported in autoimmune disorders, and are infrequently described as a paraneoplastic syndrome with cancers of lung, breast, and carcinoid tumors of the thyroid. We report a patient who presented with severe vomiting, blurring of vision, vertigo, diplopia, left hemiparesis and hemisensory loss and ataxia. She was found to have a longitudinally-extensive demyelinating lesion extending from the medulla to the upper cervical spinal cord on MRI. Her gastric endoscopy revealed carcinoid tumor of the stomach, and classic paraneoplastic antibodies in the serum were negative. She had extremely high serum gastrin level and high titer of NMO IgG autoantibody. The patient made an excellent recovery with tumor resection and immunotherapy, with both clinical and radiological improvement. On rare instances, NMO or NMO-SD may present as a paraneoplastic neurological syndrome associated with carcinoid tumor of the stomach.
Copyright © 2014 King Faisal Specialist Hospital & Research Centre. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autoimmune diseases; Carcinoid tumor associated with paraneoplastic; Demyelinating disease (CNS); Devic’s syndrome; Paraneoplastic syndrome

Mesh:

Year:  2014        PMID: 24954081     DOI: 10.1016/j.hemonc.2014.06.001

Source DB:  PubMed          Journal:  Hematol Oncol Stem Cell Ther


  12 in total

Review 1.  Common and Rare Manifestations of Neuromyelitis Optica Spectrum Disorder.

Authors:  Dominique Rosales; Ilya Kister
Journal:  Curr Allergy Asthma Rep       Date:  2016-06       Impact factor: 4.806

2.  Neuromyelitis optica spectrum disorder and adenocarcinoma of ovary: a novel association.

Authors:  Julie Sachdeva; Ramandeep Bansal; Aastha Takkar; Rajveer Singh
Journal:  BMJ Case Rep       Date:  2019-04-24

3.  Clinical profile of patients with paraneoplastic neuromyelitis optica spectrum disorder and aquaporin-4 antibodies.

Authors:  Maria Sepúlveda; Nuria Sola-Valls; Domingo Escudero; Bojan Rojc; Manuel Barón; Luis Hernández-Echebarría; Begoña Gómez; Josep Dalmau; Albert Saiz; Francesc Graus
Journal:  Mult Scler       Date:  2017-09-18       Impact factor: 6.312

Review 4.  Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later.

Authors:  Sean J Pittock; Claudia F Lucchinetti
Journal:  Ann N Y Acad Sci       Date:  2015-06-10       Impact factor: 5.691

5.  Paraneoplastic neuromyelitis optica spectrum disorder associated with malignant melanoma: A case report.

Authors:  Toshiki Morimoto; Shotaro Hayashida; Kei Yamasaki; Yosuke Sasahara; Tsutomu Takaki; Kazuhiro Yatera
Journal:  Thorac Cancer       Date:  2021-05-05       Impact factor: 3.500

6.  Screening for onconeural antibodies in neuromyelitis optica spectrum disorders.

Authors:  Benjamin Berger; Tilman Hottenrott; Sebastian Rauer; Oliver Stich
Journal:  BMC Neurol       Date:  2017-01-10       Impact factor: 2.474

Review 7.  Ocular Paraneoplastic Syndromes.

Authors:  Joanna Przeździecka-Dołyk; Anna Brzecka; Maria Ejma; Marta Misiuk-Hojło; Luis Fernando Torres Solis; Arturo Solís Herrera; Siva G Somasundaram; Cecil E Kirkland; Gjumrakch Aliev
Journal:  Biomedicines       Date:  2020-11-10

8.  Unilateral Arm Urticaria Presenting as a Paraneoplastic Manifestation of Metachronous Bilateral Breast Cancer.

Authors:  Pashtoon Murtaza Kasi; Tina J Hieken; Tufia C Haddad
Journal:  Case Rep Oncol       Date:  2016-01-14

Review 9.  Adaptive Immunity Is the Key to the Understanding of Autoimmune and Paraneoplastic Inflammatory Central Nervous System Disorders.

Authors:  Robert Weissert
Journal:  Front Immunol       Date:  2017-03-23       Impact factor: 7.561

Review 10.  AQP4-IgG positive paraneoplastic NMOSD: A case report and review.

Authors:  Manqiu Ding; Yue Lang; Li Cui
Journal:  Brain Behav       Date:  2021-09-14       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.